X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Packaging & Logistic

Quick Opens New Cell and Gene Therapy Center of Excellence Logistics Facility

Content Team by Content Team
4th June 2019
in Packaging & Logistic, Press Statements
Quick  logistics

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

As the trend for cell and gene therapies are becoming a commercial reality with recent FDA approvals, Quick, part of the Kuehne + Nagel Group, has opened a Cell and Gene Therapy (CGT) logistics facility in order to provide comprehensive logistics solutions and highest performance standards to support the life science community.

While healthcare and life science logistics is complex for all types of medical shipments, gene, cell, and immunotherapies have special challenges, and the logistics need to be synchronized throughout the supply chain to ensure product integrity, patient safety, and successful outcomes.

Cell and gene therapy treatments are different for each patient and require individual handling and precise timing. These new therapies are also high value, extremely time and temperature-sensitive, and require specialized handling, packaging, and proper storage.

Quick’s new 30,000 square foot state-of-the-art CGT Center of Excellence is located in Chicago, IL, with proximity to Chicago’s O’Hare airport. Designed for GDP (Good Distribution Practices) compliance, it has controlled room temperature in-transit storage and is a conditioning and storage facility for Credo units and nitrogen shippers, used for transport of CGT therapies.

Life science logistics specialists will provide clients with 24/7 customized solutions –from specially designed processes, pre-planning of routings, packaging procurement, conditioning and placement to regulatory compliance and temperature monitoring devices. Quick’s advanced IT solutions provide transparency, data integration, and real-time information.

“Quick’s investment in our new cutting edge CGT facility, recruitment of highly experienced logistics specialists and innovative technology solutions to synchronize the CGT supply chain reflects our commitment to support the life science community. We are proud to partner with pharmaceutical and biotech companies that are developing these exciting new therapies and provide them comprehensive logistics support,” says David Murphy, Executive Vice President, Quick Specialized Healthcare Logistics.

About Quick Specialized Healthcare Logistics
Quick is the trusted logistics leader for the healthcare and life science industry, serving the community for nearly 40 years. Quick, part of the Kuehne + Nagel Group safely and quickly transports human organs and tissue for transplant or research, blood, blood products, cord blood, bone marrow, medical devices, and equipment, as well as cell and gene therapies.

About Kuehne + Nagel
With almost 82,000 employees at more than 1,300 locations in over 100 countries, the Kuehne + Nagel Group is one of the world’s leading logistics companies. Its strong market position lies in the seafreight, airfreight, contract logistics, and overland businesses, with a clear focus on providing IT-based integrated logistics solutions. Further information can be found at www.kuehne-nagel.com

Previous Post

CRF Bracket's World-Class Clinical Research Technology wins European PIN Award for Second Year in Row

Next Post

Hamilton And Enable Biosciences Team Up to Automate Ultra-Sensitive Antibody Detection Assay Platform

Related Posts

Packaging & Logistic

VarioFill: Rotzinger sets new standards with highly flexible filling and capping platform for OTC products

30th August 2025
Major Depressive Disorder
Americas

AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

27th August 2025
Schott-Testing
Press Statements

Carbon Reduced Pharmaceutical Glass: SCHOTT Melting Tank Construction Starts and External Certification for FIOLAX® Pro OCF

11th August 2025
Future Trends Shaping
Packaging & Logistic

Future Trends Shaping Pharma Supply Chain and Logistics

30th July 2025
GSK and Hengrui Pharma
Drug Development

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

29th July 2025
Aptar Pharma Bolsters Clinical Trial.
Clinical Trials

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

24th July 2025
Next Post
liquid biopsy samples

Hamilton And Enable Biosciences Team Up to Automate Ultra-Sensitive Antibody Detection Assay Platform

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In